-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBVIE - PHASE 3 STUDIES MET PRIMARY ENDPOINTS WITH STATISTICALLY SIGNIFICANT IMPROVEMENTS VERSUS PLACEBO

Reuters·08/04/2026 12:00:16

Please log in to view news